The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 09, 2020
Filed:
Mar. 14, 2018
Applicants:
Mark A. Latta, Omaha, NE (US);
Stephen M. Gross, Omaha, NE (US);
William A. Mchale, Collegeville, PA (US);
Inventors:
Mark A. Latta, Omaha, NE (US);
Stephen M. Gross, Omaha, NE (US);
William A. McHale, Collegeville, PA (US);
Assignee:
Premier Dental Products Company, Plymouth Meeting, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 8/11 (2006.01); A61K 6/00 (2020.01); A61K 8/19 (2006.01); A61K 8/21 (2006.01); A61K 8/24 (2006.01); A61Q 5/06 (2006.01); A61Q 3/02 (2006.01); A61K 9/00 (2006.01); A61K 9/50 (2006.01); A61K 33/06 (2006.01); A61K 33/16 (2006.01); A61K 33/44 (2006.01); A61K 47/02 (2006.01); A61Q 11/00 (2006.01); A61Q 5/02 (2006.01); A61K 8/64 (2006.01); A61Q 5/12 (2006.01); A61Q 19/00 (2006.01); A61K 8/87 (2006.01); A61K 6/20 (2020.01); A61K 6/69 (2020.01); A61K 6/71 (2020.01);
U.S. Cl.
CPC ...
A61K 8/11 (2013.01); A61K 6/20 (2020.01); A61K 6/69 (2020.01); A61K 6/71 (2020.01); A61K 8/19 (2013.01); A61K 8/21 (2013.01); A61K 8/24 (2013.01); A61K 8/64 (2013.01); A61K 8/87 (2013.01); A61K 9/0056 (2013.01); A61K 9/5031 (2013.01); A61K 9/5089 (2013.01); A61K 33/06 (2013.01); A61K 33/16 (2013.01); A61K 33/44 (2013.01); A61K 47/02 (2013.01); A61Q 3/02 (2013.01); A61Q 5/02 (2013.01); A61Q 5/06 (2013.01); A61Q 5/12 (2013.01); A61Q 11/00 (2013.01); A61Q 19/00 (2013.01); A61K 2800/412 (2013.01);
Abstract
A microcapsule composition comprising at least one polymer substantially disposed as a semi-permeable shell around a buffered solution and at least one therapeutic agent, wherein the therapeutic agent permeates the shell, and wherein the composition is suitable for delivery to a mammal. This invention also provides related compositions, products and methods.